Metabolic switch in cancer – Survival of the fittest
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Fulltext
Final published version, 1.57 MB, PDF document
Cell metabolism is characterised by the highly coordinated conversion of nutrients into energy and biomass. In solid cancers, hypoxia, nutrient deficiencies, and tumour vasculature are incompatible with accelerated anabolic growth and require a rewiring of cancer cell metabolism. Driver gene mutations direct malignant cells away from oxidation to maximise energy production and biosynthesis while tumour-secreted factors degrade peripheral tissues to fuel disease progression and initiate metastasis. As it is vital to understand cancer cell metabolism and survival mechanisms, this review discusses the metabolic switch and current drug targets and clinical trials. In the future, metabolic markers may be included when phenotyping individual tumours to improve the therapeutic opportunities for personalised therapy.
Original language | English |
---|---|
Journal | European Journal of Cancer |
Volume | 180 |
Pages (from-to) | 30-51 |
Number of pages | 22 |
ISSN | 0959-8049 |
DOIs | |
Publication status | Published - 2023 |
Bibliographical note
Publisher Copyright:
© 2022 The Author(s)
- Biosynthesis, Energy production, Hypoxia, Metabolic reprogramming, Nutrient exploitation, Wasting syndrome
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 331079029